The mammalian circadian pacemaker resides in the paired suprachiasmatic nuclei (SCN). Clock genes are the genes that control the circadian rhythms of physiology and behavior. The eŠectiveness and toxicity of many drugs vary depending on dosing time associated with 24-h rhythms of biochemical, physiological, and behavioral processes under the control of the circadian clock. However, many drugs are still administered without regard to the time of day. Identiˆca-tion of a rhythmic marker for selecting dosing time will lead to improved progress and diŠusion of chronopharmacotherapy. The monitoring of rhythmic markers may be useful in choosing the most appropriate time of day for administration of drugs and may increase their therapeutic eŠects and/or reduce their side eŠects. On the other hand, several drugs can cause alterations in 24-h rhythms, leading to illness and altered homeostatic regulation. Here, we show the disruptive eŠect of interferon on the rhythm of locomotor activity, body temperature, and clock gene mRNA expression in the periphery and SCN. The alteration of the clock function, a new concept of adverse eŠects, can be overcome by devising a dosing schedule that minimizes adverse drug eŠects on clock function. Furthermore, to produce new rhythmicity by manipulating the conditions of living organs using rhythmic administration of altered feeding schedules or several drugs appears to lead to the new concept of chronopharmacotherapy. One approach to increasing the e‹cien-cy of pharmacotherapy is administering drugs at times during which they are best eŠective and/or tolerated.
Fig. 1. Model of the Molecular Clockwork in an SCN
Neuron [14] [15] [16] Heterodimers of CLK (CLOCK) and BMAL1 (MOP3) activate transcription of clock genes and clock controlled genes. The CRY (cryptochrome) proteins shut down CLOCK BMAL1 transcription in the nucleus (circle), forming a negative feedback loop (small square). PER2 stimulates the transcription of BMAL1, forming a positive feedback loop (middle square). The phosphorylation of PER1 (period) and PER2 by CKIe (casein kinase I epsilon) may regulate their cellular location and stability. Clock controlled genes products, which include PER3, DBP (D element binding protein), and AVP (arginine vasopressin), transduce the core oscillation to downstream output systems. Solid line: dosing at 08：00. Broken line: dosing at 20：00. Each value is the mean with SE of 8 subjects. 24-hr change in peak expiratory ‰ow (PEF) of the 8 asthmatics treated with theophylline (bottom). Solid line: dosing at 08：00. Broken line: dosing at 20：00. Each value is the mean with SE of 8 subjects. Dosing in the evening results in a moderation in the nocturnal decline in PEF in comparison to treatment of the same patients with the same dose of drug administered at 08： 00. 
RNA 及びタンパク合成阻害や紡錘系形成阻害など Fig. 7 . Dosing Time Dependent Change of Body Weight Change after CPT-11 (100 mg/kg, i.p.) Injection at 09： 00 (□), 13：00 (△), 17：00 (○), 21：00 (■), 01：00 (▲) or 05：00 (•) 32) Body weight change was calculated as the percentage change for each mouse from the initial treatment day (day 0). Each value is the mean with SE of 10 mice. The body weight change after CPT-11 injection showed a signiˆcant dosing time dependent diŠerence ( p＜0.01). マウスを使用した．09：00, 13：00, 17：00, 21：00, 01：00, 05：00 の 6 時点のいずれかに，CPT-11
24-hr Rhythm of Leukocyte Counts in Control Mice
(○) with Saline or Mice(•) on Day 3 after CPT-11 (100 mg/kg, i.p.) Injection at 09：00, 13：00, 17：00, 21：00, 01：00 or 05：00 32) Each value is the mean with SE of 10 mice. A signiˆcant 24-hr rhythm dependence was demonstrated for leukocyte counts in both mice with saline and mice with CPT-11 ( p＜0.01, respectively). マウスを使用した．09：00, 13：00, 17：00, 21：00, Each value is the mean with SE of 10 mice. The leukocyte counts at 24 hr after G-CSF injection was signiˆcantly higher in mice injected with the drug at 07：00 than at 19：00 ( p＜0.01). マウスを使用した．09：00, 13：00, 17：00, 21：00, 01：00, 05：00 の 6 時点のいずれかに，IFN-a (10 家兎を対象に，0.65％のマレイン酸チモロールを The ratio of area under the concentration time curves (AUC) of timolol in the plasma to those in the aqueous humor or the iris ciliary body was calculated in the pigmented rabbit following the topical instillation of 25 ml of 0.65％ timolol maleate solutions at 06:00, 12:00, 18:00 or 24:00 hr. Each data represents the mean of 4-8 mice. In panels a e, RNA levels for the mPer1 (a), mPer2 (b), mPer3 (c), mBmal1 (d) or mClock (e) in the SCN in mice after a single dose of IFN-a (2 MIU/kg, s.c.) at ZT0 (closed square) or ZT12 (closed triangle), or saline (open circle) daily for 6 days. In panel f, RNA levels for mPer1 in SCN in mice at ZT2 on day 7 after a single dose of IFN-g (0.1 MIU/kg, s.c.) at ZT0 (hatched column) or ZT12 (dotted column), or saline (open column) daily for 6 days. Each value represents the mean with SE of 6 observations. All groups except for mClock in all groups and mBmal1 in groups injected with IFN-a at ZT12 show signiˆcant 24-hr rhythms (mPer1 and mPer2 in groups injected with IFN-a at ZT12; p＜0.05, respectively, others; p＜0.01, respectively).   p＜0.01,  p＜0.05, compared with the value of controls at corresponding ZTs. White bars indicate the light period, and grey bars indicate the dark period. 
